AI-generated summary
This review describes laser techniques used to treat benign prostatic hyperplasia, including cases with a median lobe, and notes that various laser methods have shown clinical efficacy in studies, some with follow-up of up to 5 years. The authors report that median lobes were not considered a contraindication for laser procedures, but that no studies focused specifically on laser treatment of median lobes have been published.
- Who or what was studied
- Men with benign prostatic hyperplasia, including those with median lobe hyperplasia
- Limits stated in the abstract
- The abstract notes that retreatment rates were higher than after TURP in some studies and that no studies specifically address laser treatment of median lobes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Contraindication. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.